NM_000235.4:c.539-5C>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000235.4(LIPA):​c.539-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 1,613,070 control chromosomes in the GnomAD database, including 48,404 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4540 hom., cov: 32)
Exomes 𝑓: 0.22 ( 43864 hom. )

Consequence

LIPA
NM_000235.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00003292
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.224
Variant links:
Genes affected
LIPA (HGNC:6617): (lipase A, lysosomal acid type) This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 10-89225233-G-A is Benign according to our data. Variant chr10-89225233-G-A is described in ClinVar as [Benign]. Clinvar id is 255610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-89225233-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIPANM_000235.4 linkc.539-5C>T splice_region_variant, intron_variant Intron 5 of 9 ENST00000336233.10 NP_000226.2 P38571-1
LIPANM_001127605.3 linkc.539-5C>T splice_region_variant, intron_variant Intron 5 of 9 NP_001121077.1 P38571-1
LIPANM_001288979.2 linkc.191-5C>T splice_region_variant, intron_variant Intron 3 of 7 NP_001275908.1 P38571A0A0A0MT32
LIPAXM_024448023.2 linkc.539-5C>T splice_region_variant, intron_variant Intron 5 of 9 XP_024303791.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIPAENST00000336233.10 linkc.539-5C>T splice_region_variant, intron_variant Intron 5 of 9 1 NM_000235.4 ENSP00000337354.5 P38571-1

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31723
AN:
152006
Hom.:
4533
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.320
Gnomad ASJ
AF:
0.237
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.325
Gnomad FIN
AF:
0.255
Gnomad MID
AF:
0.306
Gnomad NFE
AF:
0.189
Gnomad OTH
AF:
0.221
GnomAD3 exomes
AF:
0.289
AC:
72636
AN:
251068
Hom.:
14075
AF XY:
0.282
AC XY:
38316
AN XY:
135730
show subpopulations
Gnomad AFR exome
AF:
0.101
Gnomad AMR exome
AF:
0.472
Gnomad ASJ exome
AF:
0.237
Gnomad EAS exome
AF:
0.738
Gnomad SAS exome
AF:
0.315
Gnomad FIN exome
AF:
0.261
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.263
GnomAD4 exome
AF:
0.220
AC:
321511
AN:
1460946
Hom.:
43864
Cov.:
34
AF XY:
0.222
AC XY:
161564
AN XY:
726822
show subpopulations
Gnomad4 AFR exome
AF:
0.0998
Gnomad4 AMR exome
AF:
0.453
Gnomad4 ASJ exome
AF:
0.234
Gnomad4 EAS exome
AF:
0.729
Gnomad4 SAS exome
AF:
0.315
Gnomad4 FIN exome
AF:
0.259
Gnomad4 NFE exome
AF:
0.185
Gnomad4 OTH exome
AF:
0.237
GnomAD4 genome
AF:
0.209
AC:
31753
AN:
152124
Hom.:
4540
Cov.:
32
AF XY:
0.218
AC XY:
16200
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.106
Gnomad4 AMR
AF:
0.321
Gnomad4 ASJ
AF:
0.237
Gnomad4 EAS
AF:
0.729
Gnomad4 SAS
AF:
0.327
Gnomad4 FIN
AF:
0.255
Gnomad4 NFE
AF:
0.189
Gnomad4 OTH
AF:
0.222
Alfa
AF:
0.189
Hom.:
4972
Bravo
AF:
0.215
Asia WGS
AF:
0.471
AC:
1634
AN:
3478
EpiCase
AF:
0.195
EpiControl
AF:
0.188

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Lysosomal acid lipase deficiency Benign:4
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 20, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 06, 2022
GENinCode PLC
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Wolman disease Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 11, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
6.6
DANN
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000033
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2297472; hg19: chr10-90984990; COSMIC: COSV51079077; API